Selected research
Industry Research
Dalbavancin Industry Research Report 2026
Market perspective
The global Dalbavancin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dalbavancin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dalbavancin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dalbavancin include Sanofi, Novartis, Merck, Roche, Pfizer, GSK, Amgen, Abbvie and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dalbavancin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dalbavancin Market by Company
Sanofi
Novartis
Merck
Roche
Pfizer
GSK
Amgen
Abbvie
Johnson
Hayao
Gilead
Dalbavancin Segment by Type
Intravenous Therapy
Oral Type
Dalbavancin Segment by Application
Skin Infection
Soft Tissue Infection
Others
Dalbavancin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalbavancin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dalbavancin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalbavancin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dalbavancin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dalbavancin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Therapy
- Oral Type
Applications
- Skin Infection
- Soft Tissue Infection
- Others
Companies covered
- Sanofi
- Novartis
- Merck
- Roche
- Pfizer
- GSK
- Amgen
- Abbvie
- Johnson
- Hayao
- Gilead
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dalbavancin Market Size (2021-2032)
- 2.2.2 Global Dalbavancin Sales (2021-2032)
- 2.2.3 Global Dalbavancin Market Average Price (2021-2032)
- 2.3 Dalbavancin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intravenous Therapy
- 2.3.3 Oral Type
- 2.4 Dalbavancin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Skin Infection
- 2.4.3 Soft Tissue Infection
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dalbavancin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dalbavancin Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Dalbavancin Revenue of Manufacturers (2021-2026)
- 3.4 Global Dalbavancin Average Price by Manufacturers (2021-2026)
- 3.5 Global Dalbavancin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dalbavancin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dalbavancin, Product Type & Application
- 3.8 Global Manufacturers of Dalbavancin, Established Date
- 3.9 Global Dalbavancin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Dalbavancin Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Dalbavancin Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Dalbavancin Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Roche
- 4.4.1 Roche Company Information
- 4.4.2 Roche Business Overview
- 4.4.3 Roche Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Dalbavancin Product Portfolio
- 4.4.5 Roche Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Dalbavancin Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Dalbavancin Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Amgen
- 4.7.1 Amgen Company Information
- 4.7.2 Amgen Business Overview
- 4.7.3 Amgen Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Amgen Dalbavancin Product Portfolio
- 4.7.5 Amgen Recent Developments
- 4.8 Abbvie
- 4.8.1 Abbvie Company Information
- 4.8.2 Abbvie Business Overview
- 4.8.3 Abbvie Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Abbvie Dalbavancin Product Portfolio
- 4.8.5 Abbvie Recent Developments
- 4.9 Johnson
- 4.9.1 Johnson Company Information
- 4.9.2 Johnson Business Overview
- 4.9.3 Johnson Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Johnson Dalbavancin Product Portfolio
- 4.9.5 Johnson Recent Developments
- 4.10 Hayao
- 4.10.1 Hayao Company Information
- 4.10.2 Hayao Business Overview
- 4.10.3 Hayao Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hayao Dalbavancin Product Portfolio
- 4.10.5 Hayao Recent Developments
- 4.11 Gilead
- 4.11.1 Gilead Company Information
- 4.11.2 Gilead Business Overview
- 4.11.3 Gilead Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Gilead Dalbavancin Product Portfolio
- 4.11.5 Gilead Recent Developments
5 Global Dalbavancin Market Scenario by Region
- 5.1 Global Dalbavancin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dalbavancin Sales by Region: 2021-2032
- 5.2.1 Global Dalbavancin Sales by Region: 2021-2026
- 5.2.2 Global Dalbavancin Sales by Region: 2027-2032
- 5.3 Global Dalbavancin Revenue by Region: 2021-2032
- 5.3.1 Global Dalbavancin Revenue by Region: 2021-2026
- 5.3.2 Global Dalbavancin Revenue by Region: 2027-2032
- 5.4 North America Dalbavancin Market Facts & Figures by Country
- 5.4.1 North America Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dalbavancin Sales by Country (2021-2032)
- 5.4.3 North America Dalbavancin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dalbavancin Market Facts & Figures by Country
- 5.5.1 Europe Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dalbavancin Sales by Country (2021-2032)
- 5.5.3 Europe Dalbavancin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dalbavancin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dalbavancin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dalbavancin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dalbavancin Market Facts & Figures by Country
- 5.7.1 South America Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dalbavancin Sales by Country (2021-2032)
- 5.7.3 South America Dalbavancin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dalbavancin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dalbavancin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dalbavancin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dalbavancin Sales by Type (2021-2032)
- 6.1.1 Global Dalbavancin Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Dalbavancin Sales Market Share by Type (2021-2032)
- 6.2 Global Dalbavancin Revenue by Type (2021-2032)
- 6.2.1 Global Dalbavancin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dalbavancin Revenue Market Share by Type (2021-2032)
- 6.3 Global Dalbavancin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dalbavancin Sales by Application (2021-2032)
- 7.1.1 Global Dalbavancin Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Dalbavancin Sales Market Share by Application (2021-2032)
- 7.2 Global Dalbavancin Revenue by Application (2021-2032)
- 7.2.1 Global Dalbavancin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dalbavancin Revenue Market Share by Application (2021-2032)
- 7.3 Global Dalbavancin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dalbavancin Value Chain Analysis
- 8.1.1 Dalbavancin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dalbavancin Production Mode & Process
- 8.2 Dalbavancin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dalbavancin Distributors
- 8.2.3 Dalbavancin Customers
9 Global Dalbavancin Analyzing Market Dynamics
- 9.1 Dalbavancin Industry Trends
- 9.2 Dalbavancin Industry Drivers
- 9.3 Dalbavancin Industry Opportunities and Challenges
- 9.4 Dalbavancin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst